Is hydroxyurea leukemogenic in essential thrombocythemia?: Response

被引：0
|
作者：
Fenaux, P [1 ]
Preudhomme, C [1 ]
Laï, JL [1 ]
Sterkers, Y [1 ]
机构：
[1] CHU Lille, Dept Hematol, F-59037 Lille, France
来源：
BLOOD | 1998年 / 92卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1460 / 1461
页数：2
相关论文
共 50 条
  • [41] Prevalence and clinical outcomes of polycythemia vera and essential thrombocythemia with hydroxyurea resistance or intolerance
    Chiaranairungrot, Kittitat
    Kaewpreechawat, Komkrich
    Sajai, Chanwit
    Pagowong, Narueporn
    Sukarat, Nissa
    Piriyakhuntorn, Pokpong
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Chai-Adisaksopha, Chatree
    Tantiworawit, Adisak
    Norasetthada, Lalita
    Rattarittamrong, Ekarat
    HEMATOLOGY, 2022, 27 (01) : 813 - 819
  • [42] The Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients with Essential Thrombocythemia
    Podoltsev, Nikolai A.
    Zhu, Mengxin
    Zeidan, Amer M.
    Wang, Rong
    Davidoff, Amy J.
    Giri, Smith
    Huntington, Scott
    Gore, Steven D.
    Ma, Xiaomei
    BLOOD, 2017, 130
  • [43] Hydroxyurea for essential thrombocythemia: Balancing the risk of leukemia with the benefits of controlling thrombocytosis.
    de la Serna, J
    Hernandez, B
    Bornstein, R
    Cedena, T
    Martin, ML
    Lahuerta, JJ
    BLOOD, 1998, 92 (10) : 424A - 424A
  • [44] Therapeutic options for patients with polycythemia vera and essential thrombocythemia refractory/resistant to hydroxyurea
    Sever, Matjaz
    Newberry, Kate J.
    Verstovsek, Srdan
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2685 - 2690
  • [45] Clinical Evaluation of the European LeukemiaNet Criteria for Resistance/Intolerance to Hydroxyurea In Essential Thrombocythemia
    Besses, Carles
    Alvarez-Larran, Alberto
    Gomez, Montserrat
    Angona, Anna
    Amat, Paula
    Bellosillo, Beatriz
    Martinez-Aviles, Luz
    Navarro, Blanca
    Isabel Teruel, Ana
    Martinez-Ruiz, Francisco
    Carlos Hernandez-Boluda, Juan
    BLOOD, 2010, 116 (21) : 1663 - 1663
  • [46] Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia
    Enriqueta Albizua
    Miguel Gallardo
    Santiago Barrio
    Inmaculada Rapado
    Ana Jimenez
    Rosa Ayala
    Daniel Rueda
    Beatriz Sanchez-Espiridion
    Eulalia Puigdecanet
    Blanca Espinet
    Lourdes Florensa
    Carles Besses
    Joaquin Martinez-Lopez
    Annals of Hematology, 2011, 90 : 939 - 946
  • [47] Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia
    Albizua, Enriqueta
    Gallardo, Miguel
    Barrio, Santiago
    Rapado, Inmaculada
    Jimenez, Ana
    Ayala, Rosa
    Rueda, Daniel
    Sanchez-Espiridion, Beatriz
    Puigdecanet, Eulalia
    Espinet, Blanca
    Florensa, Lourdes
    Besses, Carles
    Martinez-Lopez, Joaquin
    ANNALS OF HEMATOLOGY, 2011, 90 (08) : 939 - 946
  • [48] Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment
    Remenyi, Gyula
    Szasz, Robert
    Debreceni, Ildiko Beke
    Szarvas, Mariann
    Batar, Peter
    Nagy, Bela, Jr.
    Kappelmayer, Janos
    Udvardy, Miklos
    PLATELETS, 2013, 24 (06) : 486 - 492
  • [49] Late-onset radiation necrosis of the larynx attributed to hydroxyurea taken for essential thrombocythemia
    Tokunaga, Masahiro
    Yamato, Akiyuki
    Inohara, Hidenori
    Maeda, Tetsuo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025,
  • [50] Is hydroxyurea leukemogenic in children with sickle cell disease?
    de Montalembert, M
    Davies, SC
    BLOOD, 2001, 98 (09) : 2878 - 2879
12345